Campagna Jason 4
4 · INTERCEPT PHARMACEUTICALS, INC. · Filed Jan 26, 2021
Insider Transaction Report
Form 4
Campagna Jason
Chief Medical Officer
Transactions
- Award
Common Stock
2021-01-22+12,600→ 20,531 total - Award
Option to Purchase Common Stock
2021-01-22+19,700→ 19,700 totalExercise: $29.46Exp: 2031-01-22→ Common Stock (19,700 underlying)
Footnotes (2)
- [F1]Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of restricted stock unit awards previously granted to the reporting person.
- [F2]Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of restricted stock and restricted stock unit awards previously granted to the reporting person.